Clinical Trial Update: A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating a humanized CD19 CAR-T cell therapy with TLR2 for adults with naive B-cell acute lymphoblastic leukemia/lymphoblastic lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma

Drugs mentioned

• Humanized CD19 CAR-T Cells With TLR2 (CD19-directed CAR-T cells with TLR2 co-stimulation)

Snippet

Sponsor: Zhujiang Hospital | Conditions: B Lymphoblastic Leukemia/Lymphoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING